BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grabiner BC, Blonska M, Lin PC, You Y, Wang D, Sun J, Darnay BG, Dong C, Lin X. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev. 2007;21:984-996. [PMID: 17438001 DOI: 10.1101/gad.1502507] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Motawi TK, El-Maraghy SA, Sharaf SA, Said SE. Association of CARD10 rs6000782 and TNF rs1799724 variants with paediatric-onset autoimmune hepatitis. J Adv Res 2019;15:103-10. [PMID: 30581618 DOI: 10.1016/j.jare.2018.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Hachmann J, Salvesen GS. The Paracaspase MALT1. Biochimie 2016;122:324-38. [PMID: 26386283 DOI: 10.1016/j.biochi.2015.09.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
3 Rosebeck S, Rehman AO, Lucas PC, McAllister-Lucas LM. From MALT lymphoma to the CBM signalosome: three decades of discovery. Cell Cycle 2011;10:2485-96. [PMID: 21750409 DOI: 10.4161/cc.10.15.16923] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 6.2] [Reference Citation Analysis]
4 Karim ZA, Vemana HP, Khasawneh FT. MALT1-ubiquitination triggers non-genomic NF-κB/IKK signaling upon platelet activation. PLoS One 2015;10:e0119363. [PMID: 25748427 DOI: 10.1371/journal.pone.0119363] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
5 Kahle JJ, Gulbahce N, Shaw CA, Lim J, Hill DE, Barabási AL, Zoghbi HY. Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia. Hum Mol Genet 2011;20:510-27. [PMID: 21078624 DOI: 10.1093/hmg/ddq496] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
6 Pan D, Lin X. Epithelial growth factor receptor-activated nuclear factor κB signaling and its role in epithelial growth factor receptor-associated tumors. Cancer J 2013;19:461-7. [PMID: 24270344 DOI: 10.1097/PPO.0000000000000001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
7 Frank T, Niemann I, Reichel A, Stamminger T. Emerging roles of cytomegalovirus-encoded G protein-coupled receptors during lytic and latent infection. Med Microbiol Immunol 2019;208:447-56. [PMID: 30900091 DOI: 10.1007/s00430-019-00595-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Israël L, Glück A, Berger M, Coral M, Ceci M, Unterreiner A, Rubert J, Bardet M, Ginster S, Golding-Ochsenbein AM, Martin K, Hoyler T, Calzascia T, Wieczorek G, Hillenbrand R, Ferretti S, Ferrero E, Bornancin F. CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo. Oncogenesis 2021;10:32. [PMID: 33824280 DOI: 10.1038/s41389-021-00321-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Lin FT, Lin VY, Lin VT, Lin WC. TRIP6 antagonizes the recruitment of A20 and CYLD to TRAF6 to promote the LPA2 receptor-mediated TRAF6 activation. Cell Discov 2016;2:15048. [PMID: 27134758 DOI: 10.1038/celldisc.2015.48] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xia ZX, Li ZX, Zhang M, Sun LM, Zhang QF, Qiu XS. CARMA3 regulates the invasion, migration, and apoptosis of non-small cell lung cancer cells by activating NF-кB and suppressing the P38 MAPK signaling pathway. Exp Mol Pathol 2016;100:353-60. [PMID: 26526492 DOI: 10.1016/j.yexmp.2015.10.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
11 Sun L, Ye RD. Role of G protein-coupled receptors in inflammation. Acta Pharmacol Sin 2012;33:342-50. [PMID: 22367283 DOI: 10.1038/aps.2011.200] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 8.6] [Reference Citation Analysis]
12 Xie C, Han Y, Fu L, Li Q, Qiu X, Wang E. Overexpression of CARMA3 is associated with advanced tumor stage, cell cycle progression, and cisplatin resistance in human epithelial ovarian cancer. Tumour Biol 2014;35:7957-64. [PMID: 24833094 DOI: 10.1007/s13277-014-2070-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
13 Jiang C, Zhou Z, Quan Y, Zhang S, Wang T, Zhao X, Morrison C, Heise MT, He W, Miller MS, Lin X. CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection. Cell Rep. 2016;14:2389-2401. [PMID: 26947079 DOI: 10.1016/j.celrep.2016.02.031] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
14 Jiang C, Lin X. Regulation of NF-κB by the CARD proteins. Immunol Rev 2012;246:141-53. [PMID: 22435552 DOI: 10.1111/j.1600-065X.2012.01110.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
15 Kohno T, Kubo Y, Yasui K, Haraguchi M, Shigematsu S, Chua KJ, Matsuyama T, Hayashi H. Serum starvation activates NF-κB through G protein β2 subunit-mediated signal. DNA Cell Biol 2012;31:1636-44. [PMID: 22917497 DOI: 10.1089/dna.2012.1666] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
16 Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH, Friis-Hansen L. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer. 2012;11:71. [PMID: 22992343 DOI: 10.1186/1476-4598-11-71] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
17 Staal J, Driege Y, Haegman M, Kreike M, Iliaki S, Vanneste D, Lork M, Afonina IS, Braun H, Beyaert R. Defining the combinatorial space of PKC::CARD‐CC signal transduction nodes. FEBS J 2021;288:1630-47. [DOI: 10.1111/febs.15522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Li Z, Qu L, Dong Q, Huang B, Li H, Tang Z, Xu Y, Luo W, Liu L, Qiu X, Wang E. Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression. PLoS One 2012;7:e36903. [PMID: 22615840 DOI: 10.1371/journal.pone.0036903] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
19 Hsieh WC, Chuang YT, Chiang IH, Hsu SC, Miaw SC, Lai MZ. Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap-/- mice. Blood 2014;124:2847-57. [PMID: 25190756 DOI: 10.1182/blood-2014-03-564609] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
20 Shi R, Re D, Dudl E, Cuddy M, Okolotowicz KJ, Dahl R, Su Y, Hurder A, Kitada S, Peddibhotla S, Roth GP, Smith LH, Kipps TJ, Cosford N, Cashman J, Reed JC. Chemical biology strategy reveals pathway-selective inhibitor of NF-kappaB activation induced by protein kinase C. ACS Chem Biol 2010;5:287-99. [PMID: 20141195 DOI: 10.1021/cb9003089] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
21 Hou H, Li WX, Cui X, Zhou DC, Zhang B, Geng XP. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate. World J Gastroenterol 2019; 25(36): 5483-5493 [PMID: 31576094 DOI: 10.3748/wjg.v25.i36.5483] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ashrafizadeh M, Hushmandi K, Hashemi M, Akbari ME, Kubatka P, Raei M, Koklesova L, Shahinozzaman M, Mohammadinejad R, Najafi M, Sethi G, Kumar AP, Zarrabi A. Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer. Biomolecules 2020;10:E1159. [PMID: 32784711 DOI: 10.3390/biom10081159] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
23 Scudiero I, Vito P, Stilo R. The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders. J Cell Physiol. 2014;229:990-997. [PMID: 24375035 DOI: 10.1002/jcp.24543] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
24 Jiang C, Zhu Y, Zhou Z, Gumin J, Bengtsson L, Wu W, Songyang Z, Lang FF, Lin X. TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression. Oncogene 2017;36:2813-23. [DOI: 10.1038/onc.2016.430] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
25 Rau CS, Yang JC, Chen YC, Wu CJ, Lu TH, Tzeng SL, Wu YC, Hsieh CH. Lipopolysaccharide-induced microRNA-146a targets CARD10 and regulates angiogenesis in human umbilical vein endothelial cells. Toxicol Sci 2014;140:315-26. [PMID: 24863965 DOI: 10.1093/toxsci/kfu097] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
26 Man X, He J, Kong C, Zhu Y, Zhang Z. Clinical significance and biological roles of CARMA3 in human bladder carcinoma. Tumour Biol 2014;35:4131-6. [PMID: 24443255 DOI: 10.1007/s13277-013-1540-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
27 Zotti T, Polvere I, Voccola S, Vito P, Stilo R. CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders. Front Immunol 2018;9:2167. [PMID: 30319628 DOI: 10.3389/fimmu.2018.02167] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
28 Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, Ruland J, Scheidereit C, Krappmann D. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J 2007;26:4634-45. [PMID: 17948050 DOI: 10.1038/sj.emboj.7601897] [Cited by in Crossref: 152] [Cited by in F6Publishing: 144] [Article Influence: 10.9] [Reference Citation Analysis]
29 Gehring T, Seeholzer T, Krappmann D. BCL10 - Bridging CARDs to Immune Activation. Front Immunol 2018;9:1539. [PMID: 30022982 DOI: 10.3389/fimmu.2018.01539] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
30 Juilland M, Thome M. Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling. Front Immunol 2018;9:1927. [PMID: 30214442 DOI: 10.3389/fimmu.2018.01927] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
31 Liu Q, Rao Y, Tian M, Zhang S, Feng P. Modulation of Innate Immune Signaling Pathways by Herpesviruses. Viruses 2019;11:E572. [PMID: 31234396 DOI: 10.3390/v11060572] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
32 Sun W, Li H, Yu Y, Fan Y, Grabiner BC, Mao R, Ge N, Zhang H, Fu S, Lin X, Yang J. MEKK3 is required for lysophosphatidic acid-induced NF-kappaB activation. Cell Signal 2009;21:1488-94. [PMID: 19465115 DOI: 10.1016/j.cellsig.2009.05.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
33 Causton B, Pardo-Saganta A, Gillis J, Discipio K, Kooistra T, Rajagopal J, Xavier RJ, Cho JL, Medoff BD. CARMA3 Mediates Allergic Lung Inflammation in Response to Alternaria alternata. Am J Respir Cell Mol Biol 2018;59:684-94. [PMID: 29958012 DOI: 10.1165/rcmb.2017-0181OC] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
34 Verhoef PA, Ingram JL. When It Comes to Alternaria , Instant CARMA’s Gonna Get You. Am J Respir Cell Mol Biol 2018;59:657-8. [DOI: 10.1165/rcmb.2018-0186ed] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Rodriguez M, Luo W, Weng J, Zeng L, Yi Z, Siwko S, Liu M. PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-κB. Oncogenesis 2014;3:e114. [PMID: 25111863 DOI: 10.1038/oncsis.2014.29] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
36 Zhao T, Miao Z, Wang Z, Xu Y, Wu J, Liu X, You Y, Li J. CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-κB regulation in breast cancer cells. Tumour Biol 2013;34:3041-7. [PMID: 23708960 DOI: 10.1007/s13277-013-0869-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
37 Sitcheran R, Comb WC, Cogswell PC, Baldwin AS. Essential role for epidermal growth factor receptor in glutamate receptor signaling to NF-kappaB. Mol Cell Biol 2008;28:5061-70. [PMID: 18541671 DOI: 10.1128/MCB.00578-08] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
38 Douanne T, Chapelier S, Rottapel R, Gavard J, Bidère N. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation. Cell Immunol 2020;353:104133. [PMID: 32450431 DOI: 10.1016/j.cellimm.2020.104133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Zhang S, Lin X. CARMA3: Scaffold Protein Involved in NF-κB Signaling. Front Immunol 2019;10:176. [PMID: 30814996 DOI: 10.3389/fimmu.2019.00176] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
40 Sun W, Yang J. Molecular basis of lysophosphatidic acid-induced NF-κB activation. Cell Signal 2010;22:1799-803. [PMID: 20471472 DOI: 10.1016/j.cellsig.2010.05.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
41 Chengedza S, Benbrook DM. NF-kappaB is involved in SHetA2 circumvention of TNF-alpha resistance, but not induction of intrinsic apoptosis. Anticancer Drugs 2010;21:297-305. [PMID: 20032777 DOI: 10.1097/CAD.0b013e3283350e43] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
42 Huang SK, Scruggs AM, McEachin RC, White ES, Peters-Golden M. Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lung. PLoS One 2014;9:e107055. [PMID: 25215577 DOI: 10.1371/journal.pone.0107055] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 7.6] [Reference Citation Analysis]
43 Doyon P, Servant MJ. Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells. J Biol Chem. 2010;285:30708-30718. [PMID: 20659889 DOI: 10.1074/jbc.M110.126433] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
44 Ruland J, Hartjes L. CARD–BCL-10–MALT1 signalling in protective and pathological immunity. Nat Rev Immunol 2019;19:118-34. [DOI: 10.1038/s41577-018-0087-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 15.3] [Reference Citation Analysis]
45 Funakoshi-Tago M, Miyagawa Y, Ueda F, Mashino T, Moriwaki Y, Tago K, Kasahara T, Tamura H. A bis-malonic acid fullerene derivative significantly suppressed IL-33-induced IL-6 expression by inhibiting NF-κB activation. Int Immunopharmacol 2016;40:254-64. [PMID: 27632703 DOI: 10.1016/j.intimp.2016.08.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
46 Wu X, Li J, Zhu M, Fletcher JA, Hodi FS. Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways. Mol Cancer Ther 2012;11:1905-14. [PMID: 22653968 DOI: 10.1158/1535-7163.MCT-12-0121] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
47 Kingeter LM, Schaefer BC. Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives? Cell Signal 2010;22:9-22. [PMID: 19772915 DOI: 10.1016/j.cellsig.2009.09.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
48 Ye X. Lysophospholipid signaling in the function and pathology of the reproductive system. Hum Reprod Update 2008;14:519-36. [PMID: 18562325 DOI: 10.1093/humupd/dmn023] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 6.1] [Reference Citation Analysis]
49 Miao Z, Zhao T, Wang Z, Xu Y, Song Y, Wu J, Xu H. CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression. Biochem Biophys Res Commun 2012;425:781-7. [PMID: 22884800 DOI: 10.1016/j.bbrc.2012.07.152] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
50 Sun W, Wang H, Zhao X, Yu Y, Fan Y, Wang H, Wang X, Lu X, Zhang G, Fu S, Yang J. Protein phosphatase 2A acts as a mitogen-activated protein kinase kinase kinase 3 (MEKK3) phosphatase to inhibit lysophosphatidic acid-induced IkappaB kinase beta/nuclear factor-kappaB activation. J Biol Chem 2010;285:21341-8. [PMID: 20448038 DOI: 10.1074/jbc.M110.104224] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
51 Cheng J, Hamilton KS, Kane LP. Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production. Mol Immunol 2014;59:110-6. [PMID: 24548923 DOI: 10.1016/j.molimm.2014.01.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
52 Sun J. CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseases. World J Biol Chem 2010; 1(12): 353-361 [PMID: 21537470 DOI: 10.4331/wjbc.v1.i12.353] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
53 Jiang T, Grabiner B, Zhu Y, Jiang C, Li H, You Y, Lang J, Hung MC, Lin X. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression. Cancer Res 2011;71:2183-92. [PMID: 21406399 DOI: 10.1158/0008-5472.CAN-10-3626] [Cited by in Crossref: 67] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
54 Ghanbari M, Iglesias AI, Springelkamp H, van Duijn CM, Ikram MA, Dehghan A, Erkeland SJ, Klaver CCW, Meester-Smoor MA; International Glaucoma Genetics Consortium (IGGC). A Genome-Wide Scan for MicroRNA-Related Genetic Variants Associated With Primary Open-Angle Glaucoma. Invest Ophthalmol Vis Sci 2017;58:5368-77. [PMID: 29049738 DOI: 10.1167/iovs.17-22410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
55 Klei LR, Hu D, Panek R, Alfano DN, Bridwell RE, Bailey KM, Oravecz-Wilson KI, Concel VJ, Hess EM, Van Beek M, Delekta PC, Gu S, Watkins SC, Ting AT, Gough PJ, Foley KP, Bertin J, McAllister-Lucas LM, Lucas PC. MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage. Cell Rep 2016;17:221-32. [PMID: 27681433 DOI: 10.1016/j.celrep.2016.08.080] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
56 Duran A, Linares JF, Galvez AS, Wikenheiser K, Flores JM, Diaz-Meco MT, Moscat J. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 2008;13:343-54. [PMID: 18394557 DOI: 10.1016/j.ccr.2008.02.001] [Cited by in Crossref: 400] [Cited by in F6Publishing: 383] [Article Influence: 30.8] [Reference Citation Analysis]
57 Rebane A, Runnel T, Aab A, Maslovskaja J, Rückert B, Zimmermann M, Plaas M, Kärner J, Treis A, Pihlap M, Haljasorg U, Hermann H, Nagy N, Kemeny L, Erm T, Kingo K, Li M, Boldin MP, Akdis CA. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol 2014;134:836-847.e11. [PMID: 24996260 DOI: 10.1016/j.jaci.2014.05.022] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 13.7] [Reference Citation Analysis]
58 Wu GL, Yuan JL, Huang XD, Rong JF, Zhang LX, Liu YP, Wang FL. Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma. Tumour Biol 2013;34:3431-5. [PMID: 23771851 DOI: 10.1007/s13277-013-0917-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
59 Lappano R, Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov. 2011;10:47-60. [PMID: 21193867 DOI: 10.1038/nrd3320] [Cited by in Crossref: 475] [Cited by in F6Publishing: 453] [Article Influence: 47.5] [Reference Citation Analysis]
60 Zhang Y, Wei Z, Li J, Liu P. Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling. Sci China Life Sci. 2015;58:1246-1255. [PMID: 26612043 DOI: 10.1007/s11427-015-4977-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
61 Hara H, Ishihara C, Takeuchi A, Xue L, Morris SW, Penninger JM, Yoshida H, Saito T. Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9. J Immunol 2008;181:918-30. [PMID: 18606643 DOI: 10.4049/jimmunol.181.2.918] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
62 Causton B, Ramadas RA, Cho JL, Jones K, Pardo-Saganta A, Rajagopal J, Xavier RJ, Medoff BD. CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation. J Immunol. 2015;195:683-694. [PMID: 26041536 DOI: 10.4049/jimmunol.1402983] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
63 Jiang C, Lin X. Analysis of epidermal growth factor-induced NF-κB signaling. Methods Mol Biol 2015;1280:75-102. [PMID: 25736745 DOI: 10.1007/978-1-4939-2422-6_6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
64 Ge YJ, Liao QW, Xu YC, Zhao Q, Wu BL, Ye RD. Anti-inflammatory signaling through G protein-coupled receptors. Acta Pharmacol Sin 2020;41:1531-8. [PMID: 33060777 DOI: 10.1038/s41401-020-00523-1] [Reference Citation Analysis]
65 Du S, Jia L, Zhang Y, Fang L, Zhang X, Fan Y. CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion. Tumour Biol 2014;35:5965-70. [PMID: 24633921 DOI: 10.1007/s13277-014-1791-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
66 Delekta PC, Apel IJ, Gu S, Siu K, Hattori Y, McAllister-Lucas LM, Lucas PC. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome. J Biol Chem 2010;285:41432-42. [PMID: 21041303 DOI: 10.1074/jbc.M110.158949] [Cited by in Crossref: 58] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
67 Vessichelli M, Ferravante A, Zotti T, Reale C, Scudiero I, Picariello G, Vito P, Stilo R. Neuroepithelial transforming gene 1 (Net1) binds to caspase activation and recruitment domain (CARD)- and membrane-associated guanylate kinase-like domain-containing (CARMA) proteins and regulates nuclear factor κB activation. J Biol Chem 2012;287:13722-30. [PMID: 22343628 DOI: 10.1074/jbc.M111.304436] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
68 Qu C, Liu Y, Kunkalla K, Singh RR, Blonska M, Lin X, Agarwal NK, Vega F. Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphoma. Blood 2013;121:4718-28. [PMID: 23632891 DOI: 10.1182/blood-2012-12-470153] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
69 Feng X, Miao G, Han Y, Xu Y. CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line. Tumour Biol 2014;35:149-54. [PMID: 23893382 DOI: 10.1007/s13277-013-1018-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
70 Zheng G, Jiang C, Li Y, Yang D, Ma Y, Zhang B, Li X, Zhang P, Hu X, Zhao X, Du J, Lin X. TMEM43-S358L mutation enhances NF-κB-TGFβ signal cascade in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Protein Cell 2019;10:104-19. [PMID: 29980933 DOI: 10.1007/s13238-018-0563-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
71 Man X, Liu T, Jiang Y, Zhang Z, Zhu Y, Li Z, Kong C, He J. Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating β-catenin signaling pathway. Onco Targets Ther 2019;12:6309-22. [PMID: 31496734 DOI: 10.2147/OTT.S191502] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
72 Stilo R, Varricchio E, Liguoro D, Leonardi A, Vito P. A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-κB. Journal of Cell Science 2008;121:1165-71. [DOI: 10.1242/jcs.021105] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
73 Marasco D, Stilo R, Sandomenico A, Monti S, Tizzano B, de Capua A, Varricchio E, Liguoro D, Zotti T, Formisano S, Ruvo M, Vito P. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-κB activation. Biochemical Journal 2009;422:553-61. [DOI: 10.1042/bj20090055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
74 Staal J, Driege Y, Haegman M, Borghi A, Hulpiau P, Lievens L, Gul IS, Sundararaman S, Gonçalves A, Dhondt I, Pinzón JH, Braeckman BP, Technau U, Saeys Y, van Roy F, Beyaert R. Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions. Front Immunol 2018;9:1136. [PMID: 29881386 DOI: 10.3389/fimmu.2018.01136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
75 Scudiero I, Zotti T, Ferravante A, Vessichelli M, Vito P, Stilo R. Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stress-induced cell death. J Cell Physiol 2011;226:3121-31. [PMID: 21302310 DOI: 10.1002/jcp.22667] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
76 Sebban-Benin H, Pescatore A, Fusco F, Pascuale V, Gautheron J, Yamaoka S, Moncla A, Ursini MV, Courtois G. Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. Hum Mol Genet 2007;16:2805-15. [PMID: 17728323 DOI: 10.1093/hmg/ddm237] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
77 Jaworski M, Thome M. The paracaspase MALT1: biological function and potential for therapeutic inhibition. Cell Mol Life Sci 2016;73:459-73. [PMID: 26507244 DOI: 10.1007/s00018-015-2059-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 10.0] [Reference Citation Analysis]
78 Luo Y, Wu J, Zou J, Cao Y, He Y, Ling H, Zeng T. BCL10 in cell survival after DNA damage. Clin Chim Acta 2019;495:301-8. [PMID: 31047877 DOI: 10.1016/j.cca.2019.04.077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 McAuley JR, Freeman TJ, Ekambaram P, Lucas PC, McAllister-Lucas LM. CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis. Front Immunol. 2018;9:1887. [PMID: 30158935 DOI: 10.3389/fimmu.2018.01887] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
80 Medoff BD, Landry AL, Wittbold KA, Sandall BP, Derby MC, Cao Z, Adams JC, Xavier RJ. CARMA3 mediates lysophosphatidic acid-stimulated cytokine secretion by bronchial epithelial cells. Am J Respir Cell Mol Biol 2009;40:286-94. [PMID: 18757306 DOI: 10.1165/rcmb.2008-0129OC] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
81 Blonska M, Lin X. NF-κB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res. 2011;21:55-70. [PMID: 21187856 DOI: 10.1038/cr.2010.182] [Cited by in Crossref: 146] [Cited by in F6Publishing: 130] [Article Influence: 13.3] [Reference Citation Analysis]
82 Sun J, Lin X. Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation. Proc Natl Acad Sci U S A. 2008;105:17085-17090. [PMID: 18952848 DOI: 10.1073/pnas.0802701105] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
83 Mellett M. Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease. Cellular Immunology 2020;354:104147. [DOI: 10.1016/j.cellimm.2020.104147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
84 Lin J, He S, Sun X, Franck G, Deng Y, Yang D, Haemmig S, Wara AK, Icli B, Li D, Feinberg MW. MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10. FASEB J 2016;30:3216-26. [PMID: 27297585 DOI: 10.1096/fj.201500163R] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
85 D'Andrea EL, Ferravante A, Scudiero I, Zotti T, Reale C, Pizzulo M, De La Motte LR, De Maio C, Mazzone P, Telesio G, Vito P, Stilo R. The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-κB activation. PLoS One 2014;9:e116062. [PMID: 25541973 DOI: 10.1371/journal.pone.0116062] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
86 Zhang S, Pan D, Jia XM, Lin X, Zhao X. The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival. Protein Cell 2017;8:856-60. [PMID: 28717989 DOI: 10.1007/s13238-017-0441-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
87 Zhou T, Souzeau E, Sharma S, Siggs OM, Goldberg I, Healey PR, Graham S, Hewitt AW, Mackey DA, Casson RJ, Landers J, Mills R, Ellis J, Leo P, Brown MA, MacGregor S, Burdon KP, Craig JE. Rare variants in optic disc area gene CARD10 enriched in primary open-angle glaucoma. Mol Genet Genomic Med 2016;4:624-33. [PMID: 27896285 DOI: 10.1002/mgg3.248] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
88 Shyamsunder P, Sankar H, Mayakonda A, Han L, Nordin HBM, Woon TW, Shanmugasundaram M, Dakle P, Madan V, Koeffler HP. CARD10, a CEBPE target involved in granulocytic differentiation. Haematologica 2018;103:1269-77. [PMID: 29773596 DOI: 10.3324/haematol.2018.190280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
89 Lu HY, Biggs CM, Blanchard-Rohner G, Fung SY, Sharma M, Turvey SE. Germline CBM-opathies: From immunodeficiency to atopy. J Allergy Clin Immunol 2019;143:1661-73. [PMID: 31060714 DOI: 10.1016/j.jaci.2019.03.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
90 Sun W, Ge N, Yu Y, Burlingame S, Li X, Zhang M, Ye S, Fu S, Yang J. Phosphorylation of Thr-516 and Ser-520 in the kinase activation loop of MEKK3 is required for lysophosphatidic acid-mediated optimal IkappaB kinase beta (IKKbeta)/nuclear factor-kappaB (NF-kappaB) activation. J Biol Chem 2010;285:7911-8. [PMID: 20068038 DOI: 10.1074/jbc.M109.051219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
91 Fraser CC. G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer. Int Rev Immunol 2008;27:320-50. [PMID: 18853342 DOI: 10.1080/08830180802262765] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
92 Lee SJ, Ritter SL, Zhang H, Shim H, Hall RA, Yun CC. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells. Gastroenterology 2011;140:924-34. [PMID: 21134377 DOI: 10.1053/j.gastro.2010.11.054] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
93 Blonska M, Lin X. CARMA1-mediated NF-kappaB and JNK activation in lymphocytes. Immunol Rev. 2009;228:199-211. [PMID: 19290929 DOI: 10.1111/j.1600-065X.2008.00749.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 6.1] [Reference Citation Analysis]